Koers Brainstorm Cell Therapeutics Inc.
Aandelen
BCLI
US10501E2019
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,5345 USD | +0,47% | +0,47% | +95,79% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 36,36 mln. 34 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -21 mln. -19,64 mln. | Nettowinst (verlies) 2025 * | -27 mln. -25,25 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-1,9
x | K/w-verhouding 2025 * |
-1,42
x | Werknemers | 29 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 86,75% |
Recentste transcriptie over Brainstorm Cell Therapeutics Inc.
1 dag | +0,47% | ||
1 week | +0,47% | ||
Lopende maand | -5,35% | ||
1 maand | -19,02% | ||
3 maanden | +68,61% | ||
6 maanden | +231,99% | ||
Lopend jaar | +95,79% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 01-07-07 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 23-12-12 |
Chief Tech/Sci/R&D Officer | - | 12-05-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 22-09-00 |
Uri Yablonka
BRD | Director/Board Member | 47 | 06-06-14 |
Jacob Frenkel
CHM | Chairman | 81 | 30-03-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,5345 | +0,47% | 265 120 |
25-04-24 | 0,532 | -2,39% | 274 960 |
24-04-24 | 0,545 | +3,81% | 201 949 |
23-04-24 | 0,525 | -2,80% | 169 719 |
22-04-24 | 0,5401 | +1,52% | 367 454 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+95,79% | 36,36 mln. | |
+1,51% | 42,59 mld. | |
+8,57% | 40,65 mld. | |
+49,22% | 40,57 mld. | |
-12,36% | 26,77 mld. | |
+8,92% | 24,81 mld. | |
-25,13% | 18,17 mld. | |
+29,17% | 12,05 mld. | |
-3,12% | 11,7 mld. | |
+6,35% | 11,1 mld. |